Curelator
Curelator is a Cambridge, MA-based digital health company operating the N1-Headache™ mobile and web platform, which helps migraine patients and their clinicians track headache outcomes, measure therapeutic response, and identify personalized migraine risk factors. Revenue is generated through a Premium Subscription tier.
- Company typePrivate
- Founded2013
- HeadquartersCambridge, United States
- Headcount—
- GTM typeB2C
- OfferingSoftware
What Curelator does
Curelator is a Cambridge, Massachusetts-based digital health company founded in 2013 that operates the N1-Headache™ platform, a migraine management system combining a mobile application (available on iOS and Android) with a web-based clinician dashboard. The platform enables patients to track headache outcomes, measure therapeutic response in real time, and identify personalized migraine risk factors through what the company characterizes as scientific, factor-by-factor analysis. Curelator serves two customer segments: individuals with migraine seeking to understand personal triggers, and healthcare providers (primarily neurologists) who use the platform to monitor patient outcomes between visits.
The underlying technology appears to be a proprietary data-driven personalization engine, with the company asserting that its technologies, processes, and materials are subject to multiple patents, trademarks, and copyrights issued and pending worldwide. Curelator has cultivated partnerships with prominent neurologists globally and cites clinical studies as evidence supporting the platform's efficacy, positioning N1-Headache™ as an evidence-based tool rather than a generic headache diary.
Curelator operates a subscription-based revenue model with a Premium Subscription tier. Patient acquisition is hybrid: direct-to-consumer via app stores and web, and via the N1-Headache™ Clinician Code program, which enables healthcare providers to grant patients free Premium Subscription access as part of clinical care. The company is privately held as Curelator, LLC, with no disclosed institutional investors, funding rounds, or revenue figures in the available source material.
Curelator firmographics
Firmographics- Name
- Curelator
- Legal name
- Curelator, LLC
- Website
- https://curelator.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Short description
- Curelator is a Cambridge, MA-based digital health company operating the N1-Headache™ mobile and web platform, which helps migraine patients and their clinicians track headache outcomes, measure therapeutic response, and identify personalized migraine risk factors. Revenue is generated through a Premium Subscription tier.
- Ownership category
- akta.pro rank
Curelator industry classification
Industry- Product category
- Digital Health Software — Migraine Management
- NAICS
- Home Health Care Services (62161)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)
- akta.pro secondary industry
- Headache & Migraine Medicine (HLAKAIAE)
Keywords
Where Curelator is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Markets served
Curelator business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Premium Subscription: Subscription-based model with free Premium Subscription access provided to patients through the N1-Headache Clinician Code program offered by healthcare providers. Tiered access with basic free tier and premium paid features.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Premium Subscription with Clinician Code access |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Curelator product offering
Product offeringCore offering
Curelator operates the N1-Headache™ digital health platform, which combines a mobile application and a web-based dashboard to help migraine patients identify everyday factors affecting their individual migraine risk. The platform offers a free tier alongside a Premium Subscription with enhanced features, and operates a Clinician Code Program that allows healthcare providers to provide free Premium access to their migraine patients for monitoring and therapeutic response measurement.
Product overview
Curelator offers N1-Headache™, a unified digital health platform for migraine management. The platform comprises a mobile app (available on iOS and Android) and a web-based clinician dashboard that connect patients with their healthcare providers. The platform enables monitoring of individual headache outcomes, real-time measurement of therapeutic response, and identification of personalized migraine risk factors through scientific analysis. Healthcare providers can offer patients free Premium Subscription access via the N1-Headache™ Clinician Code Program.
Differentiator
Problem solved
Functional benefit
Brands
- N1-Headache™: Digital migraine management platform that helps patients discover everyday factors affecting migraine risk through a mobile app and web-based dashboard.
Products and services
- N1-Headache™ Platform
Companies that use Curelator
Customer profileSegments2 records
Ideal customer profiles2 records
Curelator technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Curelator partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Prominent Neurologists (Global)coreN1-Headache's partnerships with prominent neurologists around the world have generated findings that deepen understanding of migraine. These partnerships enable evidence-based personalized management of migraine through clinical studies and research collaborations.
Scale indicators1 record
Recent moves5 records
Expansion highlights3 records
Curelator competitors and assessment
Company assessmentDirect peers
- Healint: Healint operates Migraine Buddy, the most widely used consumer migraine tracking app. It is the closest direct peer to N1-Headache — same target patient, same tracking/analysis paradigm, same mobile-first distribution, and similar clinician-facing positioning.
- BonTriage: BonTriage provides a clinician-referred digital headache and migraine assessment platform. Comparable to Curelator in targeting the patient–clinician workflow around headache diagnosis and risk factor identification, though more focused on triage than ongoing tracking.
Emerging players
- Big Health: Big Health commercializes digital therapeutics (e.g., Sleepio, Daylight) into payer and clinician channels. Comparable to Curelator in digital health delivery and payer/provider GTM, though focused on insomnia and anxiety rather than migraine.
- Akili Interactive: Akili is a prescription digital therapeutics company with FDA-authorized cognitive therapy apps. It is a relevant emerging peer in the digital therapeutics category and shares Curelator's challenge of driving clinician adoption and payer coverage for software-based therapy.
- Click Therapeutics: Click Therapeutics develops prescription digital therapeutics across neurology and other indications. It is comparable as a software-based, evidence-driven digital therapeutic company pursuing both consumer and clinician/payer channels.
- Theranica: Theranica develops Nerivio, an FDA-cleared digital therapeutic wearable for migraine. It overlaps with Curelator in digital migraine therapeutics and provider-prescribed channels, but competes via a connected device rather than a pure software platform.
Broad incumbents
- AbbVie: AbbVie markets Botox for chronic migraine and Ubrelvy. It is a broad incumbent in migraine therapeutics with the neurologist relationships and scale that Curelator must navigate to grow provider adoption.
- Eli Lilly: Lilly markets Emgality and other CGRP-based migraine therapies and is a broad incumbent in migraine treatment. Comparable as a major counterparty for clinician relationships and as a potential strategic acquirer or partner that could bundle digital tools with its migraine franchise.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Curelator social profiles
Digital presenceCurelator financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curelator leadership team
Management profileNumber of profiles
Curelator funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curelator M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curelator
What does Curelator do?
Curelator operates the N1-Headache™ digital health platform, which combines a mobile application and a web-based dashboard to help migraine patients identify everyday factors affecting their individual migraine risk. The platform offers a free tier alongside a Premium Subscription with enhanced features, and operates a Clinician Code Program that allows healthcare providers to provide free Premium access to their migraine patients for monitoring and therapeutic response measurement.
Is Curelator a public or private company?
Curelator is a private company. It is classified as unknown and is currently operating.
When was Curelator founded?
Curelator was founded in 2013.
Where is Curelator based?
Curelator is headquartered in Cambridge, United States, in the North America region.
How does Curelator make money?
One revenue line is on record: premium Subscription.
Who are Curelator's main competitors?
Direct peers on record are Healint and BonTriage. Emerging players are Big Health, Akili Interactive, Click Therapeutics and Theranica. Broad incumbents are AbbVie and Eli Lilly.
Does Curelator have an API?
No public API is recorded for Curelator.
What industry is Curelator in?
Curelator's product category is Digital Health Software — Migraine Management. Its primary akta.pro industry code is HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms, with a secondary code of HLAKAIAE, Headache & Migraine Medicine. Its NAICS code is 62161 and its SIC code is 8090.